Low-Dose Group of Tuberculosis Patients (2.5U/0.1ml):Intradermally inject 0.1ml of Mycobacterium tuberculosis antigen (EM) into either the left or right arm of the patients
Sponsors
Wuhan Pulmonary Hospital
Conditions
Pulmonary Tuberculosis
Phase 1
A Phase I, single-center, open-label clinical study on the safety, tolerability, and preliminary efficacy of Mycobacterium tuberculosis antigen (EM) for skin testing in patients with tuberculosis and healthy participants
Active, not recruitingChiCTR2500112887
Start: 2023-11-30Updated: 2025-11-24
A Phase I, single-center, open-label clinical study on the safety, tolerability, and preliminary efficacy of Mycobacterium tuberculosis antigen (EM) for skin testing in patients with tuberculosis and healthy participants
Active, not recruitingChiCTR2600118400
Start: 2023-11-30Updated: 2026-02-09